Everand Logo

Welcome to Everand!

  • STAT

    Listen: Wall Street’s coronavirus freakout, why clinical trials frustrate patients, and a journey through the past

    It's the 100th episode of our biotech #podcast, "The Readout LOUD"! After talking #coronavirus and clinical trials, we revisit the first episode to update the big stories of yesteryear and…
    by Damian Garde and Rebecca Robbins and Adam Feuerstein Feb 27, 2020 1 minute

    Is the market overreacting to the coronavirus? Why do so many clinical trials go unfilled? And how do you pronounce “Martin Shkreli”?

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

    Related Books & Audiobooks